We also found that the presence of metabolic syndrome, excessive daytime sleepiness, lower maintenance insomnia complaint, and markers of chronic inflammation (CRP) were also risk factors for this syndrome in insomnia sufferers, unlike self-reported severity of depression, antidepressant therapy, smoking, alcohol consumption, and benzodiazepines and Z-drugs use. The gene discussed is CRP; the disease is insomnia measurement.